DRX CHOICE FIBER THERAPY- methylcellulose tablet 
RARITAN PHARMACEUTICALS INC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DRx Choice Fiber Therapy Methylcellulose 500 mg 100 Caplets

Active ingredient (in each caplet)

Methylcellulose (a non-allergenic fiber) 500mg

Purpose

Bulk-forming laxative

Uses

relieves occasional constipation (irregularity)
generally produces a bowel movement in 12 -72 hours.

Warnings

Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking .Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

Ask a doctor before use if you have

a sudden change in bowel habits that persists over a period of two weeks
abdominal pain, nausea or vomiting

Stop use and ask a doctor if

constipation lasts more than 7 days
you have rectal bleeding

These could be signs of a serious condition.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away at 1-800-222-1222.

Directions

Take this product (child or adult dose) with at least 8 ounces (a full glass) of water or other fluid.

Taking this product without enough liquid may cause choking.
 
See choking warning.

Age

Dose

Maximum Dose

adults & children 12 years of age and over

start with 2 caplets. Increase as needed up to 6 times per day.

Do not exceed 12 caplets per day

Children 6-11 years of age

Start with 1 caplet. Increase as needed up to 6 times per day

Do not exceed 6 caplets per day

children under 6 years of age

Consult a physician

Consult a physician

Other information

each caplet contains: calcium 18 mg
store at room temperature.
protect contents from humidity
keep tightly closed

Inactive ingredients

adipic acid, calcium carbonate, crospovidone, FD&C yellow no. 6 lake, magnesium stearate, microcrystalline cellulose, polysorbate 80, silica.

Do not use if printed seal under cap is torn or missing.

Questions or comments?

1-866-467-2748

Principal Display Panel

DRx Choice®

NDC 68163-122-00

Compare to the active Ingredients in Citrucel® Caplets *

Methylcellulose

Fiber Therapy

NaN
Gentle and clinically proven effective†

Manufactured by:

Raritan Pharmaceuticals

8 Joanna Court,

East Brunswick, NJ 08816

†When Used as Directed

††Based On Laboratory Testing. Individual Results May Vary.

*This product is not manufactured or distributed by GlaxoSmithKline, the owner of the registered trademark Citrucel® Caplets.

DRx Choice fiber therapy methylcellulose 100 Caplets
DRX CHOICE FIBER THERAPY 
methylcellulose tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68163-122
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
METHYLCELLULOSE (4000 MPA.S) (UNII: MRJ667KA5E) (METHYLCELLULOSE (4000 MPA.S) - UNII:MRJ667KA5E) METHYLCELLULOSE (4000 MPA.S)500 mg
Inactive Ingredients
Ingredient NameStrength
ADIPIC ACID (UNII: 76A0JE0FKJ)  
CALCIUM CARBONATE (UNII: H0G9379FGK)  
CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
Product Characteristics
ColorORANGE (Light orange) Scoreno score
ShapeCAPSULE (Caplet) Size19mm
FlavorImprint Code RP122
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68163-122-00100 in 1 BOTTLE; Type 0: Not a Combination Product07/20/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33407/20/2022
Labeler - RARITAN PHARMACEUTICALS INC (127602287)

Revised: 9/2023
Document Id: 2c692e71-b563-491d-b998-ae80d7b4a38f
Set id: 5e5749f7-074e-4bbc-9f33-5090e603fdb4
Version: 2
Effective Time: 20230902
 
RARITAN PHARMACEUTICALS INC